Photosensitivity, phototesting, and photoprotection in cutaneous lupus erythematosus.
Cutaneous lupus erythematosus (CLE) is a heterogeneous autoimmune disease involving well-defined skin lesions that can be categorized as acute CLE (ACLE), subacute CLE (SCLE), chronic CLE (CCLE), or intermittent CLE (ICLE). It is commonly accepted that ultraviolet (UV) exposure can induce and exacerbate skin lesions in patients with certain subtypes of CLE. Phototesting with UVA and UVB irradiation using a standardized protocol has proven to be a reliable model to study photosensitivity in CLE and to analyse the underlying pathomechanisms of the disease. In addition to UV-mediated induction of apoptosis, the molecular and cellular factors that may underlie the abnormal long-lasting photoreactivity in CLE include mediators of inflammation such as cytokines and chemokines, inducible nitric oxide (NO) synthase (iNOS), and cellular adhesion molecules. The photosensitivity associated with CLE requires education of the patient about avoidance of excessive sun exposure, continuous photoprotection through physical measures such as protective clothing, and daily application of broad-spectrum sunscreens. Novel approaches to UV-protection, such as alpha-MSH or thymidine dinucleotides, might also have an impact on photosensitivity in patients with CLE. In this review, we summarize the current knowledge about photosensitivity in patients with CLE, including an overview of standardized phototesting procedures, possible molecular pathomechanisms, and photoprotection.
Kuhn
A
A
Department of Dermatology, University of Münster, Münster, Germany. kuhnan@uni-muenster.de
Ruland
V
V
Bonsmann
G
G
D017209:Apoptosis / Q000276:immunology; D006801:Humans; D018836:Inflammation Mediators / Q000276:immunology; D008178:Lupus Erythematosus, Cutaneous / Q000276:immunology / Q000473:pathology*; D010787:Photosensitivity Disorders / Q000209:etiology / Q000276:immunology; D011481:Protective Clothing; D011835:Radiation Protection / Q000379:methods; D012867:Skin / Q000276:immunology / Q000473:pathology*; D012882:Skin Tests / Q000379:methods; D013473:Sunscreening Agents / Q000008:administration & dosage / Q000494:pharmacology; D014466:Ultraviolet Rays / Q000009:adverse effects*
D018836:Inflammation Mediators; D013473:Sunscreening Agents